Spontaneous Fibrinolysis Demonstrated by Immunological Technique

Summary

The occurrence of spontaneous fibrinolysis has been investigated in various medical diseases, e. g. myocardial infarction, cerebral stroke, phlebothrombosis, pulmonary embolism, metastasing cancer, and others. Serum from patients has been tested for fibrinolytic break-down products by use of immunodiffusion and Immunoelectrophoresis with double-diffusion. It was anticipated that positive results might provide useful diagnostic, prognostic, and therapeutic information, particularly in patients with myocardial infarction. However, there is no apparent correlation between the occurrence of spontaneous fibrinolysis and the course of disease.

In patients with haemorrhagic diathesis the tests give useful information, but in the remaining groups tested, the significance of occurring fibrinolytic break-down products cannot yet be evaluated.

• References

• 1 Chakrabarti R, Hocking E. R, Fearnley G. R. Fibrinolytic Effect of Metformin in Coronary-Artery Disease. Lancet II: 256-259 1965;
• 2 Fearnley G. R. Fibrinolysis. Edward Arnold (Publishers) Ltd.; London: 1965
• 3 Fearnley G. R, Chakrabarti R. Pharmacological enhancement of fibrinolytic activity of blood. J. clin. Path 17: 328-332 1964;
• 4 Fearnley G. R, Chakrabarti R. The pharmacological enhancement of blood fibrinolytic activity with special reference to Phenformin. Acta cardiol 19: 1-13 1964;
• 5 Gormsen J, Hansen J. M. Coexistence of Hypercoagulability and Hyperfibrinolysis in Vitro Following Prostatectomy for Benign Hypertrophy. Acta chir. Scand 122: 471-475 1961;
• 6 Gormsen J, Laursen B. Fibrinogen Breakdown Products and Clotting Parameters. (In preparation.)
• 7 Grabar P, Williams C. A. Méthode immuno-électrophoretique d’analyse de mélanges de substances antigéniques. Biochim. biophys. Acta 17: 67-74 1955;
• 8 Koller F. Intravascular Clotting and Spontaneous Fibrinolysis. Acta haemat. (Basel) 31: 239-246 1964;
• 9 Laursen B. Fibrinogen and Fibrin Breakdown Products Demonstrated by Immunodiffusion and Immunoelectrophoresis. (In preparation.)
• 10 Niléhn J.-E, Nilsson I. M. Demonstration of Fbrinolytic Split Products in Human Serum by an Immunological Method in Spontaneous and Induced Fibrinolytic States. Scand. J. Haemat 1: 313-330 1964;
• 11 Nussenzweig V, Seligman M. Analyse, par des méthodes immunochimiques, de la degradation par la plasmine du fibrinogène humain et de la fibrine, a différentes stades. Rev. Hématol 15: 451-466 1960;
• 12 Ouchterlony Ö. Antigen-Antibody Reactions in Gels. Arkiv Kemi, Mineral, Geol. 26, no. 14 1948
• 13 von Kaulla K. N. Intravenous Protein-Free Pyrogen. A Powerful Fibrinolytic Agent in Man. Circulation 17: 187-198 1958;
• 14 Wadsworth C, Hanson L. Å. Comparative Analysis of Immune-electrophoresis Precipitates Employing a Modified Electrophoretic Technique. Intern. Arch. Allergy 17: 165-177 1960;